Want to join the conversation?
$BIIB said Bioverativ will continue commercialization of ELOCTATE and ALPROLIX, indicated for treatment of hemophilia A and B under $BIIB's existing collaboration agreement with Swedish Orphan Biovitrum AB. After spin-off, Bioverativ expects to continue development of ELOCTATE and ALPROLIX. Bioverativ plans to trade under "BIVV" ticker.
$PYPL jumps 6% in after hours on strong results. I am bullish on this stock.
$TSCO stock remained active in the after hours trading and rose more than 2% after the retailer posted better than expected 1Q17 results.
Instagram has reached 700 million monthly active users. Looks like it will hit 1 billion soon. That would make it $FB’s fourth billion-user platform.